傲農生物(603363.SH):傲農畜牧投資擬向河北傲華增資 持股降至80%
格隆匯8月19日丨傲農生物(603363.SH)公佈,河北傲華農業發展有限公司(以下簡稱“河北傲華”)系公司子公司福建傲農畜牧投資有限公司(以下簡稱“傲農畜牧投資”)的控股子公司,目前註冊資本300萬元,其中傲農畜牧投資認繳出資255萬元,持股85%,雷支成認繳出資30萬元,持股10%,李興強認繳出資15萬元,持股5%。
傲農畜牧投資擬與雷支成、李興強、於林波、李鵬、晉烜及河北傲華共同簽訂股權合作協議,向河北傲華增資700萬元,新增加的700萬元註冊資本由傲農畜牧投資以貨幣方式出資545萬元,雷支成以貨幣方式出資90萬元,李興強以貨幣方式出資35萬元,新股東於林波、李鵬、晉烜分別以貨幣出資10萬元。本次增資後,河北傲華註冊資本變更為1,00萬元,其中傲農畜牧投資持股80%,雷支成持股12%,李興強持股5%,於林波持股1%,李鵬持股1%,晉烜持股1%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.